Menu
Revolutionising how to control the human immune and inflammatory response to disease
ABOUT US
Santersus
Santersus is a therapeutic apheresis company developing extracorporeal removal of cell-free DNA from patient plasma.
OUR TECHNOLOGY
Neutrophil Extracellular Traps (NETs)
Neutrophil Extracellular Traps (NETs) are fibers of decondensed DNA decorated with cytotoxic proteins that have been released from activated neutrophils. NETs have been recognized as one of the major driving factors in the development of sepsis, COVID-19, cancer, acute organ failure, autoimmune flares, and neurodegeneration including Alzheimer’s disease.
OUR DEVICE
NucleoCapture Therapeutic Apheresis Column
Santersus has developed NucleoCapture, an investigational single-use adsorption column for the removal of cell-free DNA from plasma.
APPLICATIONS
Clinical applications
Recent studies have clearly demonstrated that the massive release of NETs into the systemic bloodstream plays a pivotal role in the progression of certain acute fatal and chronic debilitating conditions.
